Amandine B.
- Country
- France
- Department
- Nuclear medicine
Research Overview
- Evaluation of Retreatment Protocols with Lutetium (177Lu) Oxodotreotide in Patients with Progressive Intestinal Well-Differentiated Neuroendocrine Tumors
- Randomized Controlled Trial of RYZ101 Versus Standard of Care in Advanced SSTR+ Gastroenteropancreatic Neuroendocrine Tumors Post-177Lu-SSA Therapy
- Phase II Randomized Trial of Lutetium (177Lu) Oxodotreotide Dosing Intervals in Grade 1-2 Advanced Midgut Neuroendocrine Tumors to Assess Hematological Toxicity
Data & Insights
Has run more than one trial at 19 of 58 partner sites.
Specializations
Neuroendocrine Oncology
The investigator specializes in treating neuroendocrine tumors, with particular expertise in thoracic manifestations affecting the lung and thymus. Their clinical focus encompasses the management of well to moderately differentiated neuroendocrine tumors requiring systematic therapeutic intervention.
- Thoracic Neuroendocrine Tumors
- Systemic Therapy Approaches
- Progressive Disease Management
Their research interests include advanced therapeutic modalities like Peptide Receptor Radionuclide Therapy (PRRT) and targeted treatments in neuroendocrine oncology.
Nuclear Medicine Applications
The investigator focuses on innovative applications of radiopharmaceutical therapy, particularly utilizing Lutetium-177 based compounds for treating neuroendocrine tumors. Their work encompasses evaluation of novel therapeutic approaches in nuclear medicine.
- Radiopharmaceutical Treatments
- Targeted Radionuclide Therapy
- Treatment Response Assessment
Their expertise extends to monitoring disease progression and therapeutic response using advanced imaging and clinical assessment protocols.
Comparative Therapeutics
The investigator's work involves evaluating different therapeutic approaches for advanced neuroendocrine tumors, including comparisons between targeted molecular therapies and nuclear medicine interventions. Their research examines treatment efficacy through progression-free survival metrics.
- Treatment Efficacy Assessment
- Clinical Outcomes Analysis
- Therapeutic Strategy Optimization
Their investigations contribute to establishing optimal treatment pathways for patients with thoracic neuroendocrine tumors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.